Transcranial magnetic stimulation in depression--lessons from the multicentre trials

Area of Science:

• Neuroscience
• Psychiatry
• Medical Technology

Background:

• Major depressive disorder lacks novel treatments, necessitating new strategies for treatment resistance.
• Repetitive transcranial magnetic stimulation (rTMS) is a potential therapeutic option for depression.
• FDA-approved rTMS devices exist for treatment-resistant depression.

Purpose of the Study:

• To review the current evidence on the efficacy of rTMS for treating depression.
• To critically discuss findings from meta-analyses and multicenter trials of rTMS in depression.
• To provide recommendations for future research in rTMS for depression.

Main Methods:

• Systematic review and critical discussion of existing literature.
• Summarization of meta-analyses on rTMS antidepressant effects.
• Presentation and analysis of multicenter trials involving larger patient cohorts.

Main Results:

• Numerous small, heterogeneous studies on rTMS for depression yield varied results.
• Meta-analyses provide an assessment of rTMS's antidepressant effects.
• Larger multicenter trials offer more comprehensive data, though require critical evaluation.

Conclusions:

• The clinical validity of rTMS for antidepressant treatment remains debated despite extensive research.
• Further high-quality research is essential to establish definitive conclusions on rTMS efficacy.
• Recommendations are provided for future research to clarify rTMS's role in depression treatment.